Engineers Gate Manager’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Engineers Gate Manager’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-50,215	Closed	-$1.21M	–	2130
2023 Q1	$1.21M	Buy	50,215 +18,067	+56%	+$227K	0.05%	524
2022 Q4	$340K	Buy	+32,148	New	+$259K	0.02%	1125
2022 Q2	–	Sell	-16,500	Closed	-$121K	–	2359
2022 Q1	$121K	Buy	+16,500	New	+$98.7K	﹤0.01%	1684
2021 Q4	–	Sell	-11,369	Closed	-$73K	–	2367
2021 Q3	$73K	Sell	11,369 -2,206	-16%	-$14.2K	﹤0.01%	1560
2021 Q2	$114K	Buy	13,575 +214	+2%	+$1.73K	0.01%	1483
2021 Q1	$140K	Sell	13,361 -7,795	-37%	-$110K	0.01%	1661
2020 Q4	$358K	Buy	+21,156	New	+$317K	0.02%	1179
2020 Q3	–	Sell	-48,185	Closed	-$680K	–	2069
2020 Q2	$680K	Buy	+48,185	New	+$608K	0.03%	792

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Engineers Gate Manager's PRVB Position: Q2 2023 in Review

Engineers Gate Manager sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 50,215 shares — an estimated $1.21M sold.

Engineers Gate Manager first reported a position in PRVB in Q2 2020 and held it in 8 quarters. The position peaked at $1.21M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Engineers Gate Manager reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Engineers Gate Manager sold 50,215 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $1.21M.
Engineers Gate Manager first reported a position in Provention Bio, Inc. Common Stock in Q2 2020 and held it in 8 quarters.
Engineers Gate Manager's Provention Bio, Inc. Common Stock position peaked at $1.21M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Engineers Gate Manager's 13F filing for Q2 2023, filed 14 Aug 2023.